Molecular combinations for cancer or other disease treatment
US8734859B1 · kind B1 · utility
5Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 25, 2011 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | Aug 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and medicine for treating leukemia or other cancer or disease condition including administering periodic doses of a combination of one or more of emodin, rhein or rhapontin with one or more of aucubin, digoxin or beta-sitosterol, and/or one or more of carvacrol, vanillic acid or sitosterol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.